SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019Maraviroc as a Latency Reversing Agent in cell line models - Filippo DragoniView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019Single genome sequencing of near full-length HIV-1 RNA - Laura HebberechtView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019Longitudinal analysis of proviral HIV-DNA - Eva HegerView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019The aging patient - Eugenia Negredo, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019The new patient - with what & when - Peter Reiss, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019Novel markers on HBV / HDV co-infection - Valentina Svicher, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019Specific NS5A polymorphisms correlate with hepatocellular carcinoma in cirrhotic patients infected with HCV genotype 1b - Mohammad AltkhatibView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019Clinical case- Rocio Montejano Sanchez, MDView Slideset
AMAnne-Geneviève MarcelinMDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019First line therapies: implications for long term resistance - Anne-Geneviève Marcelin, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019Presentations from scientists from the industry- Luisa Stamm, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019Epidemiological study of Doravirine associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy - Anne-Geneviéve MarcelinView Slideset
AKAlina KirichenkoMDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2019High prevalence of the integrase resistance associated accessory mutation L74I in the Russian Federation- Alina KirichenkoView Slideset
